Semler Scientific Faces Class Action Lawsuit Over Securities Violations
ByAinvest
Tuesday, Oct 7, 2025 2:31 am ET1min read
SMLR--
The class action lawsuit, which has already been filed, seeks to recover damages on behalf of investors who may have suffered losses as a result of these alleged misrepresentations. Investors are encouraged to join the case by visiting the firm’s website or contacting the law firms representing the class action.
Bronstein, Gewirtz & Grossman, LLC [1] and Levi & Korsinsky, LLP [2] are the law firms handling the case. Both firms have extensive experience representing investors in complex securities litigation and have recovered hundreds of millions of dollars for their clients. Investors have until October 28, 2025, to request that the court appoint them as lead plaintiffs.
Investors who suffered losses in Semler Scientific securities during the relevant time frame are urged to contact the Schall Law Firm before October 29, 2025. Participation in the class action is free of cost, and any recovery will be shared among class members, with the law firms receiving a contingency fee if successful.
Semler Scientific is facing a class action lawsuit for alleged violations of securities laws. Investors who purchased the company's securities between March 10, 2021, and April 15, 2025, may be eligible to participate. The lawsuit claims that the company misrepresented its financial situation and misled investors. If you are a shareholder who suffered a loss, you are encouraged to contact the Schall Law Firm before October 29, 2025.
Semler Scientific, Inc. (NASDAQ: SMLR) is currently facing a class action lawsuit alleging violations of federal securities laws. The lawsuit, filed by investors who purchased the company's securities between March 10, 2021, and April 15, 2025, claims that Semler Scientific made materially false and/or misleading statements and failed to disclose significant information. This includes not disclosing a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act, while discussing potential violations in hypothetical terms.The class action lawsuit, which has already been filed, seeks to recover damages on behalf of investors who may have suffered losses as a result of these alleged misrepresentations. Investors are encouraged to join the case by visiting the firm’s website or contacting the law firms representing the class action.
Bronstein, Gewirtz & Grossman, LLC [1] and Levi & Korsinsky, LLP [2] are the law firms handling the case. Both firms have extensive experience representing investors in complex securities litigation and have recovered hundreds of millions of dollars for their clients. Investors have until October 28, 2025, to request that the court appoint them as lead plaintiffs.
Investors who suffered losses in Semler Scientific securities during the relevant time frame are urged to contact the Schall Law Firm before October 29, 2025. Participation in the class action is free of cost, and any recovery will be shared among class members, with the law firms receiving a contingency fee if successful.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet